S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › MME › Research report
← MME page
XStocksXray
Market X-Ray report · 20 October 2026

Moneyme Ltd (MME)

Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026

Key indicators

Last closeAUD 0.067
52-week range0.059 – 0.135
Return, 1 month / 3 months+3.1% / −16.2%
Return, 1 year / 3 years−36.2% / +0.0%
TrendBelow its 200-day average
RSI (14)53
Volatility (1 year)58.7%
Worst drawdown (1 year)-54.6%
Average daily value traded0.03M AUD
Dividend yield–

Market X-Ray price-based

43/ 100 · High confidence · ahead of 40% of stocks on this exchange
Trend35
Momentum35
Stability (higher is calmer)56
Liquidity49
Income–

Five-year price chart navy: price · brown: 200-day average

-0.080.531.131.742.352021-102023-012024-042025-072026-10

About the company

MoneyMe is an Australian digital lender that provides consumer credit online. It offers personal loans, lines of credit and point-of-sale finance to retail customers, who apply through its mobile and web platform rather than visiting branches. The company is based in Australia and serves borrowers seeking fast, paperless access to credit for everyday purchases and larger expenses.

Moneyme Ltd trades under the code MME on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Moneyme Ltd (MME) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.067 on 20 October 2026.

Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 1,085 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 36.2% and over the last three months it fell 16.2%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Moneyme Ltd (MME)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend35 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-21.6%
From 52-week high-48.5%
Momentum35 · WeakLagging most stocks on this exchange.
3-month return-16.3%
6-month return-21.2%
12-month return, skipping the last month-38.1%
Stability (higher is calmer)56 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)58.7%
Worst drawdown, 1 year (smaller is calmer)-54.6%
Liquidity49 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.03M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+1.5%
1 month+3.1%
3 months−16.2%
6 months−21.2%
1 year−36.2%
3 years+0.0%
5 years–

Signals

50-day / 200-day average0.068 / 0.085
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.003

Technical summary

DailyBearish5 bullish · 2 neutral · 9 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026